Cyrus Desouza

机构：Omaha VA Medical Center, Centre for Advanced Study, Çevre, Şehircilik ve İklim Değişikliği Bakanlığı, University of Nebraska Medical Center · ORCID：0000-0001-6660-0568

发表论文 225 篇 · 总被引 9779 次 · h-index 38

代表论文

• Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial (2025 · Circulation · 被引 59)
• Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy (2025 · New England Journal of Medicine · 被引 30)
• Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes (2026 · JAMA · 被引 16)
• Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis (2025 · Diabetes Care · 被引 16)
• Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes (2025 · JAMA Internal Medicine · 被引 10)
• Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes (2026 · JAMA Internal Medicine · 被引 9)